Related Experiment Video
Updated: Aug 14, 2025

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Disruption of the interaction between mutationally activated Gαq and Gβγ attenuates aberrant signaling
Jenna L Aumiller1, Philip B Wedegaertner1
1Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Abstract:
Heterotrimeric G protein stimulation via G protein-coupled receptors promotes downstream proliferative signaling. Mutations can occur in Gα proteins which prevent GTP hydrolysis; this allows the G proteins to signal independently of G protein-coupled receptors and can result in various cancers, such as uveal melanoma (UM). Most UM cases harbor Q209L, Q209P, or R183C mutations in Gαq/11 proteins, rendering the proteins constitutively active (CA). Although it is generally thought that active, GTP-bound Gα subunits are dissociated from and signal independently of Gβγ, accumulating evidence indicates that some CA Gα mutants, such as Gαq/11, retain binding to Gβγ, and this interaction is necessary for signaling. Here, we demonstrate that disrupting the interaction between Gβγ and Gαq is sufficient to inhibit aberrant signaling driven by CA Gαq. Introduction of the I25A point mutation in the N-terminal α helical domain of CA Gαq to inhibit Gβγ binding, overexpression of the G protein Gαo to sequester Gβγ, and siRNA depletion of Gβ subunits inhibited or abolished CA Gαq signaling to the MAPK and YAP pathways. Moreover, in HEK 293 cells and in UM cell lines, we show that Gαq-Q209P and Gαq-R183C are more sensitive to the loss of Gβγ interaction than Gαq-Q209L. Our study challenges the idea that CA Gαq/11 signals independently of Gβγ and demonstrates differential sensitivity between the Gαq-Q209L, Gαq-Q209P, and Gαq-R183C mutants.
Insights
Constitutively active Gαq proteins drive cancer signaling by interacting with Gβγ. Disrupting this interaction inhibits aberrant signaling, with different Gαq mutations showing varied sensitivity to Gβγ loss.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncology
Background:
- G protein-coupled receptors (GPCRs) activate heterotrimeric G proteins, promoting cell proliferation.
- Mutations in Gα proteins can lead to constitutive activity (CA), driving cancers like uveal melanoma (UM).
- UM often involves Q209L, Q209P, or R183C mutations in Gαq/11 proteins.
Purpose of the Study:
- To investigate the role of Gβγ interaction in CA Gαq signaling.
- To determine if disrupting Gαq-Gβγ binding inhibits aberrant signaling in UM.
- To compare the sensitivity of different CA Gαq mutants to Gβγ loss.
Main Methods:
- Introducing an I25A point mutation in CA Gαq to disrupt Gβγ binding.
- Overexpressing Gαo to sequester Gβγ.
- Using siRNA to deplete Gβ subunits.
- Assessing signaling through MAPK and YAP pathways in HEK 293 and UM cell lines.
Main Results:
- Disrupting Gαq-Gβγ interaction inhibited CA Gαq signaling to MAPK and YAP pathways.
- Gαq-Q209P and Gαq-R183C mutants were more sensitive to Gβγ loss than Gαq-Q209L.
- CA Gαq signaling is not entirely independent of Gβγ.
Conclusions:
- Gαq-Gβγ interaction is crucial for aberrant signaling driven by CA Gαq.
- Targeting the Gαq-Gβγ interaction could be a therapeutic strategy for UM.
- Differential Gβγ dependence exists among common CA Gαq mutations.
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
Activation and Inactivation of G Proteins
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity
GTPases and their Regulation
Large G-proteins,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

